{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:23:19Z","timestamp":1778944999060,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdsjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jdermsci.2017.06.007","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T11:46:13Z","timestamp":1497613573000},"page":"236-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes"],"prefix":"10.1016","volume":"87","author":[{"given":"Julia","family":"Holstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Fehrenbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Br\u00fcck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"M\u00fcller-Hermelink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Carevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Schittek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran","family":"Ghoreschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska C.","family":"Eberle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9997","key":"10.1016\/j.jdermsci.2017.06.007_bib0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jdermsci.2017.06.007_bib0010","first-page":"1321","article-title":"Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin","volume":"151","author":"Wrone-Smith","year":"1997","journal-title":"Am. J. Pathol."},{"issue":"7057","key":"10.1016\/j.jdermsci.2017.06.007_bib0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature03963","article-title":"Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins","volume":"437","author":"Zenz","year":"2005","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jdermsci.2017.06.007_bib0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm1162","article-title":"Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model","volume":"11","author":"Sano","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jdermsci.2017.06.007_bib0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.jdermsci.2017.06.007_bib0030","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2133.2012.11099.x","article-title":"Psoriasis: rationale for targeting interleukin-17","volume":"167","author":"Girolomoni","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.jdermsci.2017.06.007_bib0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2013.04.028","article-title":"The role of IL-22 and Th22 cells in human skin diseases","volume":"72","author":"Fujita","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2017.06.007_bib0040","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/ncomms6621","article-title":"The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis","volume":"5","author":"Lande","year":"2014","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.jdermsci.2017.06.007_bib0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1346-8138.2011.01483.x","article-title":"Antimicrobial peptides in the pathogenesis of psoriasis","volume":"39","author":"Morizane","year":"2012","journal-title":"J. Dermatol."},{"issue":"9993","key":"10.1016\/j.jdermsci.2017.06.007_bib0050","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(15)60125-8","article-title":"Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials","volume":"386","author":"Griffiths","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jdermsci.2017.06.007_bib0055","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2133.2003.05175.x","article-title":"Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311nm) in psoriasis","volume":"148","author":"Hofmann","year":"2003","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.jdermsci.2017.06.007_bib0060","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/bjd.13744","article-title":"Psoriasis Area and Severity Index 75 rate of classical inpatient dithranol therapy under daily life conditions","volume":"173","author":"Painsi","year":"2015","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.jdermsci.2017.06.007_bib0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2230.1996.tb00143.x","article-title":"Epidermal differentiation characteristics of the psoriatic plaque during short contact treatment with dithranol cream","volume":"21","author":"van der Vleuten","year":"1996","journal-title":"Clin. Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.jdermsci.2017.06.007_bib0070","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000066450","article-title":"An immunohistochemical assessment of the response of the psoriatic lesion to single and repeated applications of high-dose dithranol cream","volume":"15","author":"Swinkels","year":"2002","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"issue":"4","key":"10.1016\/j.jdermsci.2017.06.007_bib0075","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000065972","article-title":"The response of normal human skin to single and repeated applications of dithranol cream: an immunohistochemical assessment","volume":"15","author":"Swinkels","year":"2002","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"issue":"4","key":"10.1016\/j.jdermsci.2017.06.007_bib0080","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/jphp.12019","article-title":"An investigation of the effects of dithranol-induced apoptosis in a human keratinocyte cell line","volume":"65","author":"George","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"issue":"6","key":"10.1016\/j.jdermsci.2017.06.007_bib0085","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1021\/mp200327k","article-title":"Therapeutic and cytotoxic effects of the novel antipsoriasis codrug, naproxyl-dithranol, on HaCaT cells","volume":"8","author":"Lau","year":"2011","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.jdermsci.2017.06.007_bib0090","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s000110050313","article-title":"Anthralin stimulates keratinocyte-derived proinflammatory cytokines via generation of reactive oxygen species","volume":"47","author":"Lange","year":"1998","journal-title":"Inflamm. Res."},{"issue":"4","key":"10.1016\/j.jdermsci.2017.06.007_bib0095","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1523-1747.2000.00934.x","article-title":"Anti-psoriatic drug anthralin activates JNK via lipid peroxidation: mononuclear cells are more sensitive than keratinocytes","volume":"114","author":"Peus","year":"2000","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.jdermsci.2017.06.007_bib0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.0906-6705.2004.00119.x","article-title":"Antipsoriatic drug anthralin induces EGF receptor phosphorylation in keratinocytes: requirement for H(2)O(2) generation","volume":"13","author":"Peus","year":"2004","journal-title":"Exp. Dermatol."},{"issue":"8","key":"10.1016\/j.jdermsci.2017.06.007_bib0105","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1096\/fj.04-2664fje","article-title":"The anti-psoriatic drug anthralin accumulates in keratinocyte mitochondria, dissipates mitochondrial membrane potential, and induces apoptosis through a pathway dependent on respiratory competent mitochondria","volume":"19","author":"McGill","year":"2005","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.jdermsci.2017.06.007_bib0110","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/jid.2008.321","article-title":"The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes","volume":"129","author":"Chamorro","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.jdermsci.2017.06.007_bib0115","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/1523-1747.ep12499901","article-title":"Anthralin decreases keratinocyte TGF-alpha expression and EGF-receptor binding in vitro","volume":"98","author":"Gottlieb","year":"1992","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.jdermsci.2017.06.007_bib0120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s000110050723","article-title":"Dithranol upregulates IL-10 receptors on the cultured human keratinocyte cell line HaCaT","volume":"50","author":"Farkas","year":"2001","journal-title":"Inflamm. Res."},{"issue":"8","key":"10.1016\/j.jdermsci.2017.06.007_bib0125","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1039\/C4MB00739E","article-title":"Exploring the mode of action of dithranol therapy for psoriasis: a metabolomic analysis using HaCaT cells","volume":"11","author":"Hollywood","year":"2015","journal-title":"Mol. Biosyst."},{"issue":"4","key":"10.1016\/j.jdermsci.2017.06.007_bib0130","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jaci.2015.12.1318","article-title":"Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: a randomized phase 2 study","volume":"137","author":"Krueger","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.jdermsci.2017.06.007_bib0135","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/bjd.13994","article-title":"Downmodulation of key inflammatory cell markers with a topical Janus kinase 1\/2 inhibitor","volume":"173","author":"Punwani","year":"2015","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.jdermsci.2017.06.007_bib0140","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","article-title":"IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes","volume":"174","author":"Boniface","year":"2005","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.jdermsci.2017.06.007_bib0145","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"10.1016\/j.jdermsci.2017.06.007_bib0150","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.jdermsci.2017.06.007_bib0155","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2016.06.038","article-title":"beta-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis","volume":"139","author":"Kolbinger","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.jdermsci.2017.06.007_bib0160","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0161-5890(03)00161-5","article-title":"Regulation of expression of beta-defensins: endogenous enteric peptide antibiotics","volume":"40","author":"O'Neil","year":"2003","journal-title":"Mol. Immunol."},{"issue":"11","key":"10.1016\/j.jdermsci.2017.06.007_bib0165","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.4049\/jimmunol.156.11.4514","article-title":"Anti-psoriatic drug anthralin activates transcription factor NF-kappa B in murine keratinocytes","volume":"156","author":"Schmidt","year":"1996","journal-title":"J. Immunol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181117307089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181117307089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:58:07Z","timestamp":1692842287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181117307089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0923181117307089"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2017.06.007","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2017.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}